huahaipharm(SH:600521)2015-04-20 16:00Financial Performance - Net profit attributable to shareholders rose by 91.29% to CNY 100,345,596.27 year-on-year[8] - Operating revenue grew by 39.77% to CNY 730,548,293.83 compared to the same period last year[8] - Basic earnings per share increased by 85.71% to CNY 0.13 compared to the same period last year[8] - The weighted average return on equity increased by 1.34 percentage points to 3.07%[8] - The company's operating revenue for Q1 2015 was CNY 730,548,293.83, representing a 39.77% increase compared to CNY 522,674,027.66 in the same period last year[16] - The net profit attributable to the parent company reached CNY 100,345,596.27, a significant increase of 91.29% from CNY 52,456,217.49 year-on-year[17] - Operating profit for Q1 2015 was ¥114,694,073.39, up 90.5% from ¥60,223,687.78 in Q1 2014[28] - Net profit for Q1 2015 was ¥100,163,668.00, representing an 85.2% increase compared to ¥54,118,819.78 in Q1 2014[28] Cash Flow - Net cash flow from operating activities decreased by 304.64% to -CNY 47,222,796.22 compared to the previous year[8] - The company's cash flow from operating activities showed a net outflow of CNY 47,222,796.22, a decline of 304.64% compared to a net inflow of CNY 23,076,584.78 in the previous year[17] - Investment activities generated a net cash inflow of CNY 44,661,626.37, a turnaround from a net outflow of CNY 140,873,960.95 in the previous year, mainly due to the recovery of matured financial products[17] - Cash flow from operating activities showed a total outflow of ¥745.93 million, compared to ¥587.68 million previously, indicating increased operational costs[35] - The company reported a decrease in cash received from tax refunds to ¥1.48 million from ¥9.39 million, a decline of approximately 84.2%[35] - Cash paid for employee compensation increased to ¥113.70 million from ¥95.37 million, reflecting a rise of about 19.2%[35] Assets and Liabilities - Total assets increased by 5.7% to CNY 4,767,051,511.08 compared to the end of the previous year[8] - Total current assets increased to ¥2,516,937,231.94 from ¥2,356,507,374.62, representing a growth of approximately 6.8%[21] - Total non-current assets rose to ¥2,250,114,279.14 from ¥2,153,508,778.56, marking an increase of approximately 4.5%[22] - Total liabilities as of Q1 2015 amounted to ¥1,144,192,452.23, an increase from ¥1,005,884,944.82 in the previous year[26] - Current liabilities increased to ¥1,322,636,350.33 from ¥1,196,996,134.29, representing a rise of approximately 10.5%[22] - Short-term borrowings increased by 49.42% to CNY 742,417,295.37, up from CNY 496,861,918.31, due to higher liquidity needs[15] Shareholder Information - The total number of shareholders reached 21,739 by the end of the reporting period[12] - The largest shareholder, Chen Baohua, holds 26.91% of the shares, amounting to 211,495,300 shares[12] Operational Costs - The company's gross profit margin improved, with operating costs rising by 35.64% to CNY 412,858,665.77, reflecting the increase in sales revenue[16] - The total operating cost for Q1 2015 was ¥618,594,541.83, a 31.3% increase from ¥470,892,916.15 in the same period last year[28] - The company reported a significant increase in sales expenses, which rose by 59.51% to CNY 72,253,310.03, attributed to enhanced marketing efforts[16] Future Outlook - The company plans to continue expanding its market presence and investing in new product development, although specific figures and timelines were not disclosed in the provided content[34]